N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co

Details N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co

1984-01-13

1986-02-04

Ramsuer, Robert W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

548341, A61K 31415, C07D23361

Patent

active

045686874

ABSTRACT:
This disclosure describes novel N-[.omega.-(1H-imidazol-1-yl)alkyl]arylamides which possess the property of inhibiting the enzyme thromboxane synthetase and are also useful in the treatment of hypertension and myocardial ischemia.

REFERENCES:
Stuetz et al., Chemical Abstracts, vol. 102, (1985), No. 62,244r.
Plath et al., Chemical Abstracts, vol. 94, (1981), No. 15,740f.
Wright et al., Chemical Abstracts, vol. 102, (1985), No. 78,876j.
Jaeger et al., Chemical Abstracts, vol. 83, (1975), No. 114,405e.

Affiliated with

Also associated with

Rating

N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-[2-4-(1H-Imidazol-1-yl)alkyl]-arylamides and pharmaceutical co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2341167